...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia

I have to agree Buckeyes.  There should be considerable data from BoM that will maintain the focus on the science as a whole in one way, shape or form going forward.  Even if things don’t totally pan out this time things could look a lot different 2 or 3 years down the road.....and hopefully before the May 2023 warrants expire because I’ll surely pick up many more of those at $0.05 or so if things don’t pan out this time.  But, I do think we’ll see some good things come out of this trial so best to remain optimistic.

Yes, ‘hot zone’ starting Sep 03 to Sep 16.  After that, ‘red hot zone’.

 

Share
New Message
Please login to post a reply